Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis

Implications for diabetes-induced impaired neovascularization in ischemic limb muscles

Andrea Caporali, Elisabetta Pani, Anton J G Horrevoets, Nicolle Kraenkel, Atsuhiko Oikawa, Graciela B. Sala-Newby, Marco Meloni, Brunella Cristofaro, Gallia Graiani, Aurelie S. Leroyer, Chantal M. Boulanger, Gaia Spinetti, Sung Ok Yoon, Paolo Madeddu, Costanza Emanueli

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Diabetes impairs endothelial function and reparative neovascularization. The p75 receptor of neurotrophins (p75), which is scarcely present in healthy endothelial cells (ECs), becomes strongly expressed by capillary ECs after induction of peripheral ischemia in type-1 diabetic mice. Here, we show that gene transfer-induced p75 expression impairs the survival, proliferation, migration, and adhesion capacities of cultured ECs and endothelial progenitor cells (EPCs) and inhibits angiogenesis in vitro. Moreover, intramuscular p75 gene delivery impairs neovascularization and blood flow recovery in a mouse model of limb ischemia. These disturbed functions are associated with suppression of signaling mechanisms implicated in EC survival and angiogenesis. In fact, p75 depresses the VEGF-A/Akt/eNOS/NO pathway and additionally reduces the mRNA levels of ITGB1 [beta (1) integrin], BIRC5 (survivin), PTTG1 (securin) and VEZF1. Diabetic mice, which typically show impaired postischemic muscular neovascularization and blood perfusion recovery, have these defects corrected by intramuscular gene transfer of a dominant negative mutant form of p75. Collectively, our data newly demonstrate the antiangiogenic action of p75 and open new avenues for the therapeutic use of p75 inhibition to combat diabetes-induced microvascular liabilities.

Original languageEnglish
JournalCirculation Research
Volume103
Issue number2
DOIs
Publication statusPublished - Jul 18 2008

Fingerprint

Nerve Growth Factor Receptor
Extremities
Endothelial Cells
Apoptosis
Muscles
Securin
Ischemia
Integrin beta Chains
Genes
Therapeutic Uses
Vascular Endothelial Growth Factor A
Cultured Cells
Cell Survival
Perfusion
Messenger RNA

Keywords

  • Limb ischemia
  • Neurotrophins
  • P75NTR
  • Reparative neovascularization
  • VEGF-A

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis : Implications for diabetes-induced impaired neovascularization in ischemic limb muscles. / Caporali, Andrea; Pani, Elisabetta; Horrevoets, Anton J G; Kraenkel, Nicolle; Oikawa, Atsuhiko; Sala-Newby, Graciela B.; Meloni, Marco; Cristofaro, Brunella; Graiani, Gallia; Leroyer, Aurelie S.; Boulanger, Chantal M.; Spinetti, Gaia; Yoon, Sung Ok; Madeddu, Paolo; Emanueli, Costanza.

In: Circulation Research, Vol. 103, No. 2, 18.07.2008.

Research output: Contribution to journalArticle

Caporali, A, Pani, E, Horrevoets, AJG, Kraenkel, N, Oikawa, A, Sala-Newby, GB, Meloni, M, Cristofaro, B, Graiani, G, Leroyer, AS, Boulanger, CM, Spinetti, G, Yoon, SO, Madeddu, P & Emanueli, C 2008, 'Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: Implications for diabetes-induced impaired neovascularization in ischemic limb muscles', Circulation Research, vol. 103, no. 2. https://doi.org/10.1161/CIRCRESAHA.108.177386
Caporali, Andrea ; Pani, Elisabetta ; Horrevoets, Anton J G ; Kraenkel, Nicolle ; Oikawa, Atsuhiko ; Sala-Newby, Graciela B. ; Meloni, Marco ; Cristofaro, Brunella ; Graiani, Gallia ; Leroyer, Aurelie S. ; Boulanger, Chantal M. ; Spinetti, Gaia ; Yoon, Sung Ok ; Madeddu, Paolo ; Emanueli, Costanza. / Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis : Implications for diabetes-induced impaired neovascularization in ischemic limb muscles. In: Circulation Research. 2008 ; Vol. 103, No. 2.
@article{af53fcb5f2d8484aa3cefea17fbb70b4,
title = "Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: Implications for diabetes-induced impaired neovascularization in ischemic limb muscles",
abstract = "Diabetes impairs endothelial function and reparative neovascularization. The p75 receptor of neurotrophins (p75), which is scarcely present in healthy endothelial cells (ECs), becomes strongly expressed by capillary ECs after induction of peripheral ischemia in type-1 diabetic mice. Here, we show that gene transfer-induced p75 expression impairs the survival, proliferation, migration, and adhesion capacities of cultured ECs and endothelial progenitor cells (EPCs) and inhibits angiogenesis in vitro. Moreover, intramuscular p75 gene delivery impairs neovascularization and blood flow recovery in a mouse model of limb ischemia. These disturbed functions are associated with suppression of signaling mechanisms implicated in EC survival and angiogenesis. In fact, p75 depresses the VEGF-A/Akt/eNOS/NO pathway and additionally reduces the mRNA levels of ITGB1 [beta (1) integrin], BIRC5 (survivin), PTTG1 (securin) and VEZF1. Diabetic mice, which typically show impaired postischemic muscular neovascularization and blood perfusion recovery, have these defects corrected by intramuscular gene transfer of a dominant negative mutant form of p75. Collectively, our data newly demonstrate the antiangiogenic action of p75 and open new avenues for the therapeutic use of p75 inhibition to combat diabetes-induced microvascular liabilities.",
keywords = "Limb ischemia, Neurotrophins, P75NTR, Reparative neovascularization, VEGF-A",
author = "Andrea Caporali and Elisabetta Pani and Horrevoets, {Anton J G} and Nicolle Kraenkel and Atsuhiko Oikawa and Sala-Newby, {Graciela B.} and Marco Meloni and Brunella Cristofaro and Gallia Graiani and Leroyer, {Aurelie S.} and Boulanger, {Chantal M.} and Gaia Spinetti and Yoon, {Sung Ok} and Paolo Madeddu and Costanza Emanueli",
year = "2008",
month = "7",
day = "18",
doi = "10.1161/CIRCRESAHA.108.177386",
language = "English",
volume = "103",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis

T2 - Implications for diabetes-induced impaired neovascularization in ischemic limb muscles

AU - Caporali, Andrea

AU - Pani, Elisabetta

AU - Horrevoets, Anton J G

AU - Kraenkel, Nicolle

AU - Oikawa, Atsuhiko

AU - Sala-Newby, Graciela B.

AU - Meloni, Marco

AU - Cristofaro, Brunella

AU - Graiani, Gallia

AU - Leroyer, Aurelie S.

AU - Boulanger, Chantal M.

AU - Spinetti, Gaia

AU - Yoon, Sung Ok

AU - Madeddu, Paolo

AU - Emanueli, Costanza

PY - 2008/7/18

Y1 - 2008/7/18

N2 - Diabetes impairs endothelial function and reparative neovascularization. The p75 receptor of neurotrophins (p75), which is scarcely present in healthy endothelial cells (ECs), becomes strongly expressed by capillary ECs after induction of peripheral ischemia in type-1 diabetic mice. Here, we show that gene transfer-induced p75 expression impairs the survival, proliferation, migration, and adhesion capacities of cultured ECs and endothelial progenitor cells (EPCs) and inhibits angiogenesis in vitro. Moreover, intramuscular p75 gene delivery impairs neovascularization and blood flow recovery in a mouse model of limb ischemia. These disturbed functions are associated with suppression of signaling mechanisms implicated in EC survival and angiogenesis. In fact, p75 depresses the VEGF-A/Akt/eNOS/NO pathway and additionally reduces the mRNA levels of ITGB1 [beta (1) integrin], BIRC5 (survivin), PTTG1 (securin) and VEZF1. Diabetic mice, which typically show impaired postischemic muscular neovascularization and blood perfusion recovery, have these defects corrected by intramuscular gene transfer of a dominant negative mutant form of p75. Collectively, our data newly demonstrate the antiangiogenic action of p75 and open new avenues for the therapeutic use of p75 inhibition to combat diabetes-induced microvascular liabilities.

AB - Diabetes impairs endothelial function and reparative neovascularization. The p75 receptor of neurotrophins (p75), which is scarcely present in healthy endothelial cells (ECs), becomes strongly expressed by capillary ECs after induction of peripheral ischemia in type-1 diabetic mice. Here, we show that gene transfer-induced p75 expression impairs the survival, proliferation, migration, and adhesion capacities of cultured ECs and endothelial progenitor cells (EPCs) and inhibits angiogenesis in vitro. Moreover, intramuscular p75 gene delivery impairs neovascularization and blood flow recovery in a mouse model of limb ischemia. These disturbed functions are associated with suppression of signaling mechanisms implicated in EC survival and angiogenesis. In fact, p75 depresses the VEGF-A/Akt/eNOS/NO pathway and additionally reduces the mRNA levels of ITGB1 [beta (1) integrin], BIRC5 (survivin), PTTG1 (securin) and VEZF1. Diabetic mice, which typically show impaired postischemic muscular neovascularization and blood perfusion recovery, have these defects corrected by intramuscular gene transfer of a dominant negative mutant form of p75. Collectively, our data newly demonstrate the antiangiogenic action of p75 and open new avenues for the therapeutic use of p75 inhibition to combat diabetes-induced microvascular liabilities.

KW - Limb ischemia

KW - Neurotrophins

KW - P75NTR

KW - Reparative neovascularization

KW - VEGF-A

UR - http://www.scopus.com/inward/record.url?scp=48849107004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48849107004&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.108.177386

DO - 10.1161/CIRCRESAHA.108.177386

M3 - Article

VL - 103

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 2

ER -